These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 2050425

  • 1. A randomized, dose comparison study of cefodizime in the treatment of lower urinary tract infections in women.
    Asbach HW.
    Infection; 1991; 19(2):85-7. PubMed ID: 2050425
    [Abstract] [Full Text] [Related]

  • 2. Cefodizime given once daily for the treatment of upper urinary tract infections and complicated lower urinary tract infections.
    Hofstetter AG.
    Infection; 1992; 20 Suppl 1():S18-21. PubMed ID: 1526670
    [Abstract] [Full Text] [Related]

  • 3. Cefodizime (HR221) versus norfloxacin for treatment of urinary tract infections.
    Esposito S, Sardaro C, Gaeta GB, Galante D, Giusti G, Basani F.
    J Chemother; 1991 Feb; 3(1):42-4. PubMed ID: 2019862
    [Abstract] [Full Text] [Related]

  • 4. Randomized comparative study of 0.5 and 1 g of cefodizime (HR 221) versus 1 g of cefotaxime for acute uncomplicated urogenital gonorrhea.
    van der Willigen AH, Wagenvoort JH, Schalla WO, Knapp JS, Boot JM, Heeres-Weststrate PL, Michel MF, van Klingeren B, Stolz E.
    Antimicrob Agents Chemother; 1988 Apr; 32(4):426-9. PubMed ID: 3377456
    [Abstract] [Full Text] [Related]

  • 5. An open multicentre study of the efficacy and tolerance of cefodizime 1 g bd intravenously or intramuscularly in lower respiratory tract infections.
    Sollet JP.
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():103-10. PubMed ID: 2074244
    [Abstract] [Full Text] [Related]

  • 6. Clinical safety profile of cefodizime.
    Perianu MR.
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():127-34. PubMed ID: 2074247
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Clinical evaluation and immunomodulatory study of cefodizime].
    Li G, Zhang Y, Ji M.
    Zhonghua Nei Ke Za Zhi; 1997 Nov; 36(11):759-63. PubMed ID: 10451950
    [Abstract] [Full Text] [Related]

  • 10. [Study on cefodizime, a new cephem antibiotic, in the field of pediatrics].
    Sato H, Narita A, Matsumoto K, Nakazawa S, Suzuki H, Nakanishi Y, Niino K, Nakazawa S.
    Jpn J Antibiot; 1989 Jun; 42(6):1306-21. PubMed ID: 2795855
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic study of cefodizime in experimentally infected animals.
    Arai S, Tabata S, Kobayashi S, Inazu M, Hayashi S.
    Arzneimittelforschung; 1989 Aug; 39(8):877-82. PubMed ID: 2818675
    [Abstract] [Full Text] [Related]

  • 14. Cefotaxime (HR-756) in urinary tract infections.
    Paradisi F, Cristiano P, Mirone V, D'Armiento V, Iovene MR.
    Chemotherapy; 1982 Aug; 28(1):64-9. PubMed ID: 6276110
    [Abstract] [Full Text] [Related]

  • 15. Open, controlled, randomized study on the efficacy and safety of cefodizime single daily dose versus two daily doses and versus ceftriaxone single daily dose in patients with acute purulent bronchitis and acute purulent exacerbation of chronic bronchitis.
    Zanussi C, Cocuzza G.
    J Chemother; 1995 Dec; 7(6):535-42. PubMed ID: 8667039
    [Abstract] [Full Text] [Related]

  • 16. Cefodizime in clinical use: a review of the clinical trial reports.
    Grassi GG.
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():117-25. PubMed ID: 2074246
    [Abstract] [Full Text] [Related]

  • 17. Cefodizime once daily in the treatment of lower respiratory tract infections.
    Piovano CF, Palombini BC, Dagrosa EE, Mendoza F, Facco EB.
    Arzneimittelforschung; 1997 May; 47(5):674-7. PubMed ID: 9205786
    [Abstract] [Full Text] [Related]

  • 18. Cefodizime and cefotaxime in acute exacerbations of chronic bronchitis: a randomized double-blind prospective study in 180 patients.
    Maesen FP, Davies BI, van den Bergh JJ, Gubbelmans HL, Meek JC, Geraedts WH.
    J Antimicrob Chemother; 1990 Mar; 25(3):413-22. PubMed ID: 2187013
    [Abstract] [Full Text] [Related]

  • 19. [Clinical evaluation of cefmenoxime (CMX) for complicated urinary tract infection].
    Tsuchida S, Sasaki S, Takada H, Miyagata S, Sato S, Shimizu S, Sakamoto F, Kizu N.
    Hinyokika Kiyo; 1985 Feb; 31(2):365-74. PubMed ID: 3859998
    [Abstract] [Full Text] [Related]

  • 20. In vivo activity of cefodizime.
    Shah PM, Knothe H.
    Infection; 1992 Feb; 20 Suppl 1():S9-13. PubMed ID: 1526686
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.